Director's message: Speeding up the pace of cancer research

Volume 7, Issue 3, 2018


Sobering statistics about ovarian cancer underscore the need to quickly develop novel therapies.

Robert B. Diasio, M.D.

Robert B. Diasio, M.D.

As someone who has been involved in cancer research for decades, it's exciting and gratifying to witness the proliferation of discoveries and the pace at which knowledge is being turned into treatments. Equally as exciting are discoveries that are helping us define which patients with cancer are most likely to benefit from new treatments.

One such discovery is highlighted in this issue of Forefront. Our researchers have discovered that a molecular communication pathway that was previously thought to be defective in cancer is key in determining the effectiveness of a cutting-edge virus therapy we're developing to treat brain cancer and ovarian cancer.

Our work is critically important. This month is National Ovarian Cancer Awareness Month, which highlights some sobering statistics. Each year, nearly 22,000 women are diagnosed with ovarian cancer and more than 14,000 will die of the disease.

So, while our work is expanding and moving faster than ever, we must continue to expand and speed up our efforts — lives depend on it.

  • Robert B. Diasio, M.D.
    • Director, Mayo Clinic Cancer Center
    • William J. and Charles H. Mayo Professor